March 27, 2024
Dr. Nathan Sackett Joins CaaMTech to Advise on Neuropsychiatry
Dr. Sackett also serves as the Director of the University of Washington Center for Novel Therapeutics in Addiction Psychiatry
March 27, 2024
Dr. Sackett also serves as the Director of the University of Washington Center for Novel Therapeutics in Addiction Psychiatry
September 21, 2023
Genomic sequences of various Psilocybe species revealed an unexpected wealth of genes encoding sesquiterpene synthases
September 14, 2023
The American Chemical Society will host the Chemistry of Psychedelics symposium at the 2023 Rocky Mountain Regional Meeting Sept. 14–17 the University of Wyoming
September 12, 2023
The publication of the crystal structure of 4-AcO-EPT fumarate fumaric acid also exemplifies CaaMTech’s pioneering tryptamine prodrug and SAR research
August 4, 2023
Dialkyl tryptamines have received widespread attention for their potential to treat numerous mood disorders. But secondary tryptamines, or monoalkyl tryptamines, have received almost no such attention.
March 28, 2023
4-Pro-DMT is a synthetic psilocybin analog and purported prodrug of psilocin
March 14, 2023
4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin
November 15, 2022
Researchers directly compared psilocybin with understudied magic mushroom molecules, and synthetic analogs such as psilacetin
September 22, 2022
4-HO-DiPT has been proposed as a more clinically-optimized alternative to psilocybin
September 14, 2022
Aeruginascin is a naturally-occurring quaternary tryptammonium compound found in Magic Mushrooms